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Hypoglycemia is defined as a blood glucose <70 mg/dL in a diabetic patient or a blood glucose
<50 mg/dL in a non-diabetic patient. It is a commonly encountered situation in the inpatient
population. However, it is uncommon in individuals not being treated for diabetes mellitus.
Hypoglycemic symptoms include autonomic symptoms (tremors, palpitations, anxiety,
sweating, paresthesias) and neuroglycopenic symptoms (dizziness, weakness, drowsiness,
confusion). Consequences of uncorrected hypoglycemia can lead to seizures, arrhythmias, or
other complications that may ultimately result in death. The reasons for hypoglycemia in a non-
diabetic patient can vary from medication use to uncommonly encountered disease states.
Due to the adverse risks associated with hypoglycemic episodes, it is important to pursue the
proper work-up in a timely manner, initiate measures to prevent further hypoglycemic
episodes, and ensure proper treatment aimed at the cause of the problem.
To highlight possible causes of hypoglycemia and the appropriate work-up for normally 
euglycemic patients. 
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A 36-year-old woman with lupus related end stage renal disease on hemodialysis via Ash-catheter
presented to the emergency department (ED) due to peritonitis secondary to a peritoneal dialysis (PD)
catheter that was no longer in use. Patient was bacteremic; antibiotics were started, and her PD and Ash-
catheter were removed. Repeat blood cultures were negative for over 48 hours and patient was kept
fasting at midnight (NPO) for a new Ash-catheter. The day of surgery, the patient had multiple low blood
sugar readings as low as 15mg/dL. She was asymptomatic until her blood sugar was <45. Symptoms were
limited to drowsiness and shortness of breath. She was given 4 boluses of D50, glucagon IV, and
transitioned from a D5 drip to a D15 drip that finally stabilized her blood sugar while NPO. In her chart a
blood sugar of 30 was documented 2 months prior for an admission with autoimmune hemolysis. She
denied any recollection or symptoms. She also denied a history of diabetes or low blood sugars. She
proceeded to surgery that day and went into cardiac arrest on the operating table after being sedated by
anesthesia. She was resuscitated after 1 round of CPR & a new Ash-catheter was placed. During her
hypoglycemic episodes, labs to investigate for causes of hypoglycemia were drawn (glucose, insulin, C-
peptide, proinsulin, beta-hydroxybutyrate, insulin antibodies, and sulfonylurea/meglitinide screen). These
labs returned with an inappropriately normal insulin level, high C-peptide, normal proinsulin (if diabetic),
normal BHB, and borderline positive for antibodies. The sulfonylurea/meglitinide screen was still pending.
The patient’s hypoglycemia spontaneously resolved after being allowed to resume her normal diet and she
did not require further IV dextrose. She was discharged in stable condition to a rehabilitation center with
appropriate words of caution given.
CASE DESCRIPTION
FIGURE 1: LABORATORY WORK-UP INTERPRETATION CHART
Episodes of low blood sugar seen in non-diabetic patients can stem from an array of causes: exogenous
insulin administration, an insulin secreting tumor (insulinoma), insulin antibodies, insufficient cortisol or
glucagon levels, an increase in insulin like growth factor (IGF) [due to increased growth hormone (GH)
release], improper sulfonylurea/meglitinide use or other medications, etc. Initial work-up involves
gathering further history & taking into consideration the possibility of other hormone deficiencies (cortisol).
If the cause is still inapparent, further lab work-up should be done. During a hypoglycemic episode,
measurements of glucose, insulin, IGF, C-peptide, proinsulin, & beta-hydroxybutyrate should be drawn
along with a sulfonylurea/meglitinide screen. If concern for an autoimmune pathology is present, a test
for insulin autoantibodies & anti-insulin receptor antibodies can also be drawn. Furthermore, if labs cannot
be drawn appropriately, a 72-hour fast can be conducted where these labs can be taken at specific
intervals in a controlled setting. Additionally, a Glucagon Tolerance Test can be administered to further
determine if the hypoglycemia is due to an insulin-mediated etiology (insulinoma). Ultimately, the results
of these labs should help elucidate the cause of hypoglycemia (as shown in Figure 1) & guide treatment
in the prevention of future episodes.
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